ArticleOncotarget2018

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1.

Andrew Fesler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.